Fig. 2: Efficacy analysis.

A Progression-free survival (PFS) in patients assessable for efficacy. B Progression-free survival according to the histological subtypes. Mean values are represented with their 95% confidence interval. NA not assessable.

A Progression-free survival (PFS) in patients assessable for efficacy. B Progression-free survival according to the histological subtypes. Mean values are represented with their 95% confidence interval. NA not assessable.